Kidney Res Clin Pract.
2021 Jun;40(2):180-182. 10.23876/j.krcp.21.106.
Biomarker for recurrent immunoglobulin A nephropathy in kidney allografts: promising but still a long way to go
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- KMID: 2520034
- DOI: http://doi.org/10.23876/j.krcp.21.106
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinicopathological role of kidney injury molecule-1 in immunoglobulin A nephropathy
- Treatment of Posttransplantation Recurrent Glomerulonephritis: IgA Nephropathy, Membranous Nephropathy, Membranoproliferative Glomerulonephritis
- IgA nephropathy combined with thin basement membrane nephropathy in children
- Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
- Staphylococcal infection-associated crescentic immunoglobulin A nephropathy
